STAT3 and atherosclerosis: Indeed, our results demonstrate hyperphosphorylation of both AMPK and JAK2/STAT3 signalling through MSI-1436 in acute oxLDL-challenge, which may result in a more favourable inflammatory phenotype and make beneficial effects of the compound in early atherosclerosis feasible.